HemoCue is a global leader in point-of-care diagnostics with over 40 years of experience in developing highly accurate and user-friendly diagnostic systems. Founded in the 1970s by Jan Lilja and Sven-Erik Nilsson, HemoCue has revolutionized the way hemoglobin is measured in blood by introducing portable devices that deliver lab-accurate results quickly and reliably at the point of care[1][2].
The core products of HemoCue are based on innovative microcuvette technology that enables rapid, accurate testing directly at the patient's bedside, allowing physicians to make immediate treatment decisions. These systems are used in hundreds of millions of tests annually and support healthcare professionals worldwide in the diagnosis and treatment of primarily blood disorders such as anemia, as well as other clinical conditions[1][2][4].
The main mission of HemoCue is "Advancing care, test by test, everywhere" - i.e., the continuous improvement of patient care through precise diagnostics with a focus on fast and reliable results. The company places great emphasis on caring for patients, partners and employees and works closely with healthcare stakeholders to transform diagnostic data into life-improving insights. As part of the Danaher Group, HemoCue combines state-of-the-art technology with scientific innovation to advance healthcare globally[2][3][4].
In the area of sustainability and social responsibility, the promotion of global health is a priority. HemoCue supports the improvement of access to high-quality medical diagnostics worldwide - especially in resource-poor regions. In doing so, the company contributes to reducing health inequalities and promoting sustainable health solutions[2][3].
In summary, HemoCue is characterized by a combination of decades of technical innovation, uncompromising measurement accuracy and a commitment to better healthcare. The company has established itself as a reliable partner for rapid and precise medical diagnostics and continues its vision of sustainably improving global health - test by test, worldwide[1][2][4][8].
